Dirk Müller-Wieland

21PUBLICATIONS
70CO-AUTHORS
PharmacogenomicsCardiology (incl. cardiovascular diseases)Decision makingMedical genetics (excl. cancer genetics)Decision support and group support systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 30, 2026
"Pharmacological risk stratification of Lp(a): diabetes status may refine residual cardiovascular risk beyond ASCVD history" - authors' reply.

|Jun 04, 2026
Lipoprotein(a) and residual cardiovascular risk in statin-treated patients.

|May 12, 2026
Prediction or speculation: heart failure models for diabetes.

|Apr 13, 2026
Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT Trials.

Dirk Müller-Wieland, Darren K McGuire, A Michael Lincoff

|Mar 20, 2026
Using risk scoring tools for cardiovascular risk assessment in diabetes in clinical practice.

Marlo Verket, Emanuele Di Angelantonio, Dirk Müller-Wieland

|Feb 09, 2026
Effects of coaching with data management system intervention or usual care on glycemic control in patients with type 2 diabetes: A multicentre, randomised controlled trial.

Marlo Verket, Larissa F Buitkamp, Niveditha Daneeza Dinesh Kanna

Pageof 4

Frequent Collaborators

7 joint publications

Marlo Verket

6 joint publications

Nikolaus Marx

4 joint publications

Katharina Schütt

4 joint publications

Massimo Federici